PubMed · 13046490
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
L MERCIER-PAROT. 1952. [Functional relationship between the thyroid and gonads].. https://pubmed.ncbi.nlm.nih.gov/13046490/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
In the present study we describe the evaluation of the effectiveness of gonad protection in diagnostic radiology based on the measurement of organ and the effective doses with and without lead clothing to gonads. We devised in-phantom dosimetry system and measured organ and effective doses in x-ray radiography and CT examinations with the new dosimetry system. From the data of organ and the effective doses we assessed the effectiveness of radiological protection by the use of lead clothing to gonads. Although in chest radiography and chest CT examinations, the effectiveness of radiological protection was not found, in the case of hip joint radiography (AP), gonad doses decreased remarkably by using lead clothing. The effectiveness of radiological protection, i.e. the ratio of the decreased dose to the dose value without protection, in testis and ovary were found to be 91.4% and 68.0%, respectively. It was also found that gonad doses observed with and without gonad protection were extremely lower than those of threshold for sterility recommended by the International Commission on Radiological Protection 60 (ICRP Publ. 60).
BACKGROUND AND PURPOSE: The purpose of this study was to perform in-vivo measurements of extracranial doses received by patients undergoing serial tomotherapy of the head and neck. MATERIAL AND METHODS: Intensity modulated radiotherapy treatment (IMRT) plans were designed for nine patients using the CORVUS treatment planning system (NOMOS Corp.). These plans were delivered using a tertiary collimator dedicated for serial tomotherapy attached to a 10-MV linear accelerator. For each patient, one optically stimulated luminescence dosimeter (OSLD) was placed on the sternum and one on the lower abdomen. The OSLDs were then processed, thereby estimating the in vivo absorbed doses to the sternum and gonads as a function of distance from the treatment site. RESULTS: The OSLDs were shown to measure known doses to within 5%, thereby validating their accuracy for this dose and energy range. In the patient studies, the dose received by the OSLDs varied in direct proportion to the number of monitor units delivered and inversely with the distance from the target volume; the patient dose at a distance of 15 cm from the target is approximately 0.4% of the total monitor units delivered, and drops to below 0.1% of the total MUs at approximately 40 cm from the center of the target. The average sternal dose was 1353 mSv and the average abdominal dose was 327 mSv for an average prescribed dose of 60.1 Gy. This can be attributed, at least partially, to the inefficient treatment delivery that on average required 9.9 MU/0.01 Gy. CONCLUSIONS: While IMRT reduces the normal tissue volume in the high-dose region, it also increases the overall monitor units delivered, and hence the whole-body dose, when compared with conventional treatment delivery. As has been noted in existing literature, these increases in whole-body dose from radiotherapy delivery may increase the likelihood of a radiation-induced secondary malignancy. Therefore, it is important to assess the risk of secondary malignancies from IMRT delivery, and compare this relative risk against the potential benefits of decreased normal tissue complication probabilities.
Shielding the radiosensitive gonads during X-ray exposure has been advocated for plain film radiography for many years. In the UK, gonad shields are not widely employed in routine CT scanning, possibly owing to a perceived difficulty in protecting the gonads from a multidirectional X-ray source. The increasing numbers of CT scanners in the UK, with the large doses they deliver to patients, make potential dose reduction methods an important issue. This study measures the dose reduction achievable by shielding the male gonads with a lead wrap-around protection device. The reductions in dose when shielded both from direct radiation and from indirect radiation scattered from local tissues were studied. The use of the device resulted in a statistically significant reduction in the absorbed testicular dose from both direct and scattered radiation, with no increase in the dose measured in surrounding tissues. In three clinically relevant experimental protocols where the testes were not irradiated directly, the testicular absorbed dose from indirect scatter was reduced by 77-93% of the corresponding non-shielded figure. In these three experiments, image quality was unaltered by the use of the shield. A larger dose reduction was obtained when the shield was used to protect the testes from direct irradiation. However, this was achieved at the expense of considerable image degradation from streak artefact that would effectively prevent the clinical use of the device in this setting.